Hillsdale, NJ, United States of America

G A Ganepola


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of G A Ganepola in Disease Detection

Introduction

G A Ganepola, an inventive mind based in Hillsdale, NJ, has made significant strides in the field of medical diagnostics. With a keen focus on developing advanced methodologies for disease detection, Ganepola holds one patent that provides an innovative approach to identifying neoplastic tissue within human and animal subjects.

Latest Patents

Ganepola's patented invention is titled "Discriminant function analysis method and apparatus for disease." This pioneering biopsy method and apparatus enable the determination and location of neoplastic and other disease conditions by detecting electrical potentials in the electromagnetic field of the subject. During the test period, electrical potential differences are measured at various locations in the area of the suspected neoplasm and compared to results obtained from a reference location. This analysis culminates in the identification of neoplastic tissue, followed by the precise manipulation of a biopsy instrument to procure a tissue sample for extensive study.

Career Highlights

As an integral part of Biofield Corp., Ganepola's work is a testament to the potential of innovative technologies in enhancing diagnostic procedures. Her career reflects a commitment to bridging the gap between inventive research and practical medical applications, showcasing the transformative impact of her contributions to healthcare.

Collaborations

Ganepola collaborates closely with Mark L Faupel, a fellow innovator at Biofield Corp. Their partnership underscores the importance of teamwork in driving research forward and points to the collaborative spirit that ultimately yields breakthrough innovations.

Conclusion

G A Ganepola's innovative work in the development of a discriminant function analysis method for disease diagnosis stands as a significant advancement in the medical field. With her formidable expertise and the backing of Biofield Corp., Ganepola continues to push the boundaries of medical technology, offering hope for improved diagnostic capabilities for neoplastic conditions. Her journey as an inventor illuminates the vital role that innovation plays in shaping the future of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…